Two primary trends are disrupting the use of scientific data and drug information and highlighting how the Medical Affairs workforce can be more valuable stewards of patient outcomes: the growing focus on patient outcomes and population health and the complexity of care created by scientific advancements.
By refining their roles from disease and product specialists to curators and connectors of outcomes-focused information, Medical Affairs professionals can help today’s extended ecosystem of providers, stakeholders and decision-makers capture, understand and use science to support better decisions.
Learn more how pharmaceutical companies can develop their Medical Affairs organizations into more strategic stewards of patient outcomes in the workforce of the future.